A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

NCT00823940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GSK1362885
DRUG: GSK1362885
DRUG: Glucagon
DRUG: Glucagon + GSK1362885

Sponsor

GlaxoSmithKline